Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Perrysburg, OH
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Perrysburg, OH
Click here to add this to my saved trials
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Corvallis, OR
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Corvallis, OR
Click here to add this to my saved trials
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Springfield, OR
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Springfield, OR
Click here to add this to my saved trials
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Beaver, PA
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Beaver, PA
Click here to add this to my saved trials
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Downingtown, PA
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Downingtown, PA
Click here to add this to my saved trials
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Lansdale, PA
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Lansdale, PA
Click here to add this to my saved trials
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Levittown, PA
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Levittown, PA
Click here to add this to my saved trials
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Philadelphia, PA
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Pottstown, PA
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Pottstown, PA
Click here to add this to my saved trials
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Greer, SC
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Greer, SC
Click here to add this to my saved trials
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Myrtle Beach, SC
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Bristol, TN
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Bristol, TN
Click here to add this to my saved trials
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Knoxville, TN
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Knoxville, TN
Click here to add this to my saved trials
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Memphis, TN
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Spring Hill, TN
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Spring Hill, TN
Click here to add this to my saved trials
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Austin, TX
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Marshall, TX
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Marshall, TX
Click here to add this to my saved trials
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Sugar Land, TX
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Sugar Land, TX
Click here to add this to my saved trials
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Bountiful, UT
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Bountiful, UT
Click here to add this to my saved trials
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Clinton, UT
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Clinton, UT
Click here to add this to my saved trials
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Ogden, UT
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Ogden, UT
Click here to add this to my saved trials
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Olympia, WA
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Olympia, WA
Click here to add this to my saved trials
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Port Orchard, WA
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Port Orchard, WA
Click here to add this to my saved trials
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Spokane, WA
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated:  3/16/2018
mi
from
Buenos Aires,
A Study in Patients With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study
Status: Enrolling
Updated: 3/16/2018
mi
from
Buenos Aires,
Click here to add this to my saved trials
Nutritional Regulation of Wound Inflammation: Part II
Nutritional Regulation Of Wound Inflammation: Part II
Status: Enrolling
Updated:  3/16/2018
OSU CarePoint East
mi
from
Columbus, OH
Nutritional Regulation of Wound Inflammation: Part II
Nutritional Regulation Of Wound Inflammation: Part II
Status: Enrolling
Updated: 3/16/2018
OSU CarePoint East
mi
from
Columbus, OH
Click here to add this to my saved trials
Nutritional Regulation of Wound Inflammation: Part II
Nutritional Regulation Of Wound Inflammation: Part II
Status: Enrolling
Updated:  3/16/2018
OSUWMC Comprehensive Wound Care Center, Martha Morehouse Medical Plaza
mi
from
Columbus, OH
Nutritional Regulation of Wound Inflammation: Part II
Nutritional Regulation Of Wound Inflammation: Part II
Status: Enrolling
Updated: 3/16/2018
OSUWMC Comprehensive Wound Care Center, Martha Morehouse Medical Plaza
mi
from
Columbus, OH
Click here to add this to my saved trials
Nutritional Regulation of Wound Inflammation: Part II
Nutritional Regulation Of Wound Inflammation: Part II
Status: Enrolling
Updated:  3/16/2018
The Ohio State University/Ohio State University Wexner Medical Center
mi
from
Columbus, OH
Nutritional Regulation of Wound Inflammation: Part II
Nutritional Regulation Of Wound Inflammation: Part II
Status: Enrolling
Updated: 3/16/2018
The Ohio State University/Ohio State University Wexner Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Nutritional Regulation of Wound Inflammation: Part II
Nutritional Regulation Of Wound Inflammation: Part II
Status: Enrolling
Updated:  3/16/2018
University Hospital East (Wound Center)
mi
from
Columbus, OH
Nutritional Regulation of Wound Inflammation: Part II
Nutritional Regulation Of Wound Inflammation: Part II
Status: Enrolling
Updated: 3/16/2018
University Hospital East (Wound Center)
mi
from
Columbus, OH
Click here to add this to my saved trials
Nutritional Regulation of Wound Inflammation: Part II
Nutritional Regulation Of Wound Inflammation: Part II
Status: Enrolling
Updated:  3/16/2018
University Hospital East, OSUWMC Diabetes Clinic
mi
from
Columbus, OH
Nutritional Regulation of Wound Inflammation: Part II
Nutritional Regulation Of Wound Inflammation: Part II
Status: Enrolling
Updated: 3/16/2018
University Hospital East, OSUWMC Diabetes Clinic
mi
from
Columbus, OH
Click here to add this to my saved trials
Nutritional Regulation of Wound Inflammation: Part III
Nutritional Regulation of Wound Inflammation: Part III
Status: Enrolling
Updated:  3/16/2018
University East Hospital
mi
from
Columbus, OH
Nutritional Regulation of Wound Inflammation: Part III
Nutritional Regulation of Wound Inflammation: Part III
Status: Enrolling
Updated: 3/16/2018
University East Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Nutritional Regulation of Wound Inflammation: Part III
Nutritional Regulation of Wound Inflammation: Part III
Status: Enrolling
Updated:  3/16/2018
Martha Morehouse Medical Plaza
mi
from
Columbus, OH
Nutritional Regulation of Wound Inflammation: Part III
Nutritional Regulation of Wound Inflammation: Part III
Status: Enrolling
Updated: 3/16/2018
Martha Morehouse Medical Plaza
mi
from
Columbus, OH
Click here to add this to my saved trials
Clinical Evaluation of i-STAT Analyzer Glucose, Hematocrit and Sodium for Capillary Samples
Clinical Evaluation of i-STAT Analyzer for Glucose, Hematocrit and Sodium
Status: Enrolling
Updated:  3/16/2018
Diablo Clinical Research Inc
mi
from
Walnut creek, CA
Clinical Evaluation of i-STAT Analyzer Glucose, Hematocrit and Sodium for Capillary Samples
Clinical Evaluation of i-STAT Analyzer for Glucose, Hematocrit and Sodium
Status: Enrolling
Updated: 3/16/2018
Diablo Clinical Research Inc
mi
from
Walnut creek, CA
Click here to add this to my saved trials
Clinical Evaluation of i-STAT Analyzer Glucose, Hematocrit and Sodium for Capillary Samples
Clinical Evaluation of i-STAT Analyzer for Glucose, Hematocrit and Sodium
Status: Enrolling
Updated:  3/16/2018
Kentucky Clinical Trials Laboratory
mi
from
Louisville, KY
Clinical Evaluation of i-STAT Analyzer Glucose, Hematocrit and Sodium for Capillary Samples
Clinical Evaluation of i-STAT Analyzer for Glucose, Hematocrit and Sodium
Status: Enrolling
Updated: 3/16/2018
Kentucky Clinical Trials Laboratory
mi
from
Louisville, KY
Click here to add this to my saved trials
Clinical Evaluation of i-STAT Analyzer Glucose, Hematocrit and Sodium for Capillary Samples
Clinical Evaluation of i-STAT Analyzer for Glucose, Hematocrit and Sodium
Status: Enrolling
Updated:  3/16/2018
Cleveland Clinic
mi
from
Cleveland, OH
Clinical Evaluation of i-STAT Analyzer Glucose, Hematocrit and Sodium for Capillary Samples
Clinical Evaluation of i-STAT Analyzer for Glucose, Hematocrit and Sodium
Status: Enrolling
Updated: 3/16/2018
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Mobile, AL
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Mobile, AL
Click here to add this to my saved trials
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Anaheim, CA
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Chula Vista, CA
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Chula Vista, CA
Click here to add this to my saved trials
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
La Mesa, CA
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
La Mesa, CA
Click here to add this to my saved trials
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Walnut Creek, CA
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Washington,
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Miami Gardens, FL
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Miami Gardens, FL
Click here to add this to my saved trials
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Miami, FL
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Boise, ID
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Boise, ID
Click here to add this to my saved trials
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Baltimore, MD
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Dearborn, MI
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Dearborn, MI
Click here to add this to my saved trials
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Philadelphia, PA
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Arlington, TX
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Arlington, TX
Click here to add this to my saved trials
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Dallas, TX
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
San Antonio, TX
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials